去看PFE这周季度财报
Pfizer收入同比增长32%,非covid部门才增长14%
covid特效药Paxlovid 销售从一年前2亿涨到27亿,其中美国政府花4.42亿美元囤了一百万疗程的
疫苗销售同比增长9%
"Third-quarter 2024 Paxlovid revenues of $2.7 billion increased $2.5 billion operationally compared with the prioryear quarter, primarily due to strong demand, particularly in the U.S., driven by higher utilization during a recent global COVID-19 wave; the one-time contractual delivery of one million treatment courses to the U.S. Strategic National Stockpile in the third quarter of 2024 that accounted for $442 million in revenue"